slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 73,771-73,800
Pages 3,683
Rows per page 30
Component
73,771-73,800 of 110,471
03
Bank of America | Investment Banking Pitch Book | 46 slidesBank of America | Investment Banking Pitch Book | 46 slides · Bank of America Merrill Lynch
Consulting deck Investment bank Beat · Situation & Context1 hit
05
Bank of America | Investment Banking Pitch Book | 46 slidesBank of America | Investment Banking Pitch Book | 46 slides · Bank of America Merrill Lynch
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Logic Chain1 hit
04
Includes a 'Fairness Opinion Analysis' tag in the top right.Barclays | Investment Banking Pitch Book | 33 slides · Barclays
Consulting deck Investment bank Beat · Situation & ContextLoop · Golden Circle1 hit
05
The slide uses a side-by-side comparison to illustrate the simplification of corporate structure.Barclays | Investment Banking Pitch Book | 33 slides · Barclays
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Golden Circle1 hit
24
Includes a sensitivity table for terminal yield vs. indicative growth and a summary reference range.Barclays | Investment Banking Pitch Book | 33 slides · Barclays
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
25
Includes a sensitivity table and a reference valuation range.Barclays | Investment Banking Pitch Book | 33 slides · Barclays
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
05
Bausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slidesBausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slides · Valeant
Consulting deck Investment bank Beat · Situation & Context1 hit
06
Bausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slidesBausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slides · Valeant
Consulting deck Investment bank 1 hit
07
Bausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slidesBausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slides · Valeant
Consulting deck Investment bank 1 hit
08
The slide uses a faded background image of a tree over a globe, with the first six items in bold black text and the last four in faded grey text.Bausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slides · Valeant
Consulting deck Investment bank 1 hit
09
The slide uses a hub-and-spoke style diagram to categorize revenue streams.Bausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slides · Valeant
Consulting deck Investment bank 1 hit
10
The slide uses a Steve Jobs quote to justify a non-traditional R&D strategy.Bausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slides · Valeant
Consulting deck Investment bank 1 hit
15
The slide contrasts the $35M development cost of Jublia against the industry average of $1.2B.Bausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slides · Valeant
Consulting deck Investment bank Beat · Problem & Complication1 hit
17
The chart shows a stacked bar growth trajectory from 2005 to 2014, highlighting the expansion of the product portfolio.Bausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slides · Valeant
Consulting deck Investment bank Beat · Problem & Complication1 hit
18
Bausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slidesBausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slides · Valeant
Consulting deck Investment bank Beat · Problem & Complication1 hit
19
Bausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slidesBausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slides · Valeant
Consulting deck Investment bank Beat · Problem & Complication1 hit
21
Bausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slidesBausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slides · Valeant
Consulting deck Investment bank Beat · Problem & Complication1 hit
23
Uses a standard product lifecycle / market maturity curve framework.Bausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slides · Valeant
Consulting deck Investment bank Beat · Problem & Complication1 hit
26
The slide uses a background image of a tree, likely representing growth or brand roots.Bausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slides · Valeant
Consulting deck Investment bank Beat · Solution & ApproachLoop · Aha Moment1 hit
64
The slide uses red 'x' icons to emphasize negative points about the company's R&D governance.Pershing Square | Activist Presentation Deck | 120 slides · Pershing Square Capital Management, L.P.
Activist deck Activist investor Loop · Cost Of Inaction1 hit
69
The slide uses a bar chart to contrast high historical spend with a lower-cost alternative model, highlighting potential efficiency gains.Pershing Square | Activist Presentation Deck | 120 slides · Pershing Square Capital Management, L.P.
Activist deck Activist investor Loop · Cost Of Inaction1 hit
70
The slide uses a bar chart to quantify R&D failures, supporting an activist argument against management's R&D efficiency.Pershing Square | Activist Presentation Deck | 120 slides · Pershing Square Capital Management, L.P.
Activist deck Activist investor Loop · Cost Of Inaction1 hit
72
The slide uses a 'villain' framing to attack the company's capital allocation and strategic foresight.Pershing Square | Activist Presentation Deck | 120 slides · Pershing Square Capital Management, L.P.
Activist deck Activist investor 1 hit
79
Pershing Square | Activist Presentation Deck | 120 slidesPershing Square | Activist Presentation Deck | 120 slides · Pershing Square Capital Management, L.P.
Activist deck Activist investor 1 hit
82
Uses a CEO quote to contradict the company's stated capital allocation strategy.Pershing Square | Activist Presentation Deck | 120 slides · Pershing Square Capital Management, L.P.
Activist deck Activist investor 1 hit
87
Uses a chronological narrative to expose poor capital allocation and due diligence.Pershing Square | Activist Presentation Deck | 120 slides · Pershing Square Capital Management, L.P.
Activist deck Activist investor 1 hit
93
Uses a comparison of compensation structures to highlight a governance failure at Allergan.Pershing Square | Activist Presentation Deck | 120 slides · Pershing Square Capital Management, L.P.
Activist deck Activist investor 1 hit
106
The slide uses a rhetorical question structure to cast doubt on management's motives.Pershing Square | Activist Presentation Deck | 120 slides · Pershing Square Capital Management, L.P.
Activist deck Activist investor 1 hit
111
This is a classic activist slide designed to undermine management's credibility before they even announce their new plan.Pershing Square | Activist Presentation Deck | 120 slides · Pershing Square Capital Management, L.P.
Activist deck Activist investor 1 hit
113
The slide uses a rhetorical question as a title to frame the subsequent bullet points as a rebuttal to management's potential strategy.Pershing Square | Activist Presentation Deck | 120 slides · Pershing Square Capital Management, L.P.
Activist deck Activist investor 1 hit